A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

Hartmut Döhner, Carsten Müller-Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G Ottmann, Hartmut Döhner, Carsten Müller-Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G Ottmann

No abstract available

Keywords: Aurora B kinase; BI 811283; acute myeloid leukaemia; low-dose cytarabine; phase I.